MEGAN GALANEK: Open Payments
NPI 1932656568 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 10 payments from 8 companies in 2025. Trend: 2023 $46 · 2024 $139 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $39 |
| Exact Sciences Corporation | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Braeburn Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, Veozah, The Cologuard Plus Collection Kit, TRUMENBA, BEXSERO, BRIXADI, MOUNJARO, Wegovy.
Industry payments across PA — which companies pay providers there.
